Ann Thorac Surg 2008;85:1612-1613. doi:10.1016/j.athoracsur.2008.02.088
© 2008 The Society of Thoracic Surgeons
Original Articles: Adult Cardiac
Invited Commentary
Himanshu J. Patel, MD
Section of Cardiac Surgery, University of Michigan Cardiovascular Center, CVC Room 5144, 1500 E Medical Center Dr SPC 5864, Ann Arbor, MI 48109-5864
(Email: hjpatel@med.umich.edu).
| The first 20% of the full text of this article appears below. |
Thoracic endovascular approaches are rapidly gaining favor for treating descending thoracic aortic pathology. Dick and colleagues [1] present a comparative assessment of the quality of life after open aortic repair (OAR) and thoracic endovascular aortic repair (TEVAR) of descending and thoracoabdominal aortic pathology. With the recent Food and Drug Administration's sponsored multicenter trials suggesting either improved or equivalent early outcomes, this analysis is timely and brings a very important question to the forefront for those of us practicing aortic surgery in 2008 [2, 3]. On one hand, we have OAR, which has a long track record of success, but carries with it a significant rate of morbidity and associated need for a long period . . . [Full Text of this Article]
Related Article
-
Outcome and Quality of Life After Surgical and Endovascular Treatment of Descending Aortic Lesions
- Florian Dick, Dominik Hinder, Franz F. Immer, Cédric Hirzel, Dai Do Do, Thierry P. Carrel, and Juerg Schmidli
Ann. Thorac. Surg. 2008 85: 1605-1612.
[Abstract]
[Full Text]
[PDF]
Copyright © 2008 by The Society of Thoracic Surgeons.